The antioncogenic Chk2 kinase plays a crucial role in DNA damage-induced cell-cycle checkpoint regulation. Here we show that Chk2 associates with the oncogenic protein Wip1 (wild-type p53-inducible phosphatase 1) (PPM1D), a p53-inducible protein phosphatase. Phosphorylation of Chk2 at threonine68 (Thr68), a critical event for Chk2 activation, which is normally induced by DNA damage or overexpression of Chk2, is inhibited by expression of wild-type (WT), but not a phosphatase-deficient mutant (D314A) of Wip1 in cultured cells. Furthermore, an in vitro phosphatase assay revealed that Wip1 (WT), but not Wip1 (D314A), dephosphorylates Thr68 on phosphorylated Chk2 in vitro, resulting in the inhibition of Chk2 kinase activity toward glutathione S-transferase-Cdc25C. Moreover, inhibition of Wip1 expression by RNA interference results in abnormally sustained Thr68 phosphorylation of Chk2 and increased susceptibility of cells in response to DNA damage, indicating that Wip1 acts as a negative regulator of Chk2 in response to DNA damage.
Introduction
The Chk2 tumour suppressor protein is an evolutionarily conserved nuclear protein kinase that plays a crucial role in the response to DNA damage and helps to maintain genomic stability by regulating cell cycle checkpoints, DNA repair, and apoptosis. [1] [2] [3] [4] [5] [6] [7] [8] Upon DNA damage, Chk2 is activated by phosphorylation of threonine68 (Thr68) by ATM (ataxiatelangiectasia mutated). [9] [10] [11] [12] [13] Activated Chk2 then phosphorylates its downstream effectors, including the tumour suppressors p53, BRCA1, PML, E2F-1, and Cdc25 phosphatases, [14] [15] [16] [17] [18] [19] thereby regulating cellular responses following DNA damage. Although the molecular basis of Chk2 kinase activation and roles of Chk2 in checkpoint activation are rather well understood, it remains largely unknown as to how activated Chk2 is inhibited to release from checkpoint arrest or to prevent cells from undergoing Chk2-mediated apoptosis.
In yeast cells, it has been recently reported that protein phosphatases play essential roles in inactivating cell-cycle checkpoint arrest induced by DNA damage. In Schizosaccharomyces pombe, the type I protein phosphatase Dis2 abrogates Chk1 phosphorylation and activation by dephosphorylating the phosphorylated-Ser345 in Chk1, thereby allowing mitotic entry following repair of damaged DNA. 20 On the other hand, in Saccharomyces cerevisiae, the type 2C protein phosphatases (PP2C), Ptc2 and Ptc3, bind to Rad53, the S. cerevisiae orthologue of Chk2, and inactivate Rad53 presumably by dephosphorylating Rad53, leading to checkpoint inactivation upon a DNA double-strand break. 21 Thus, it can be assumed that protein phosphatases may mediate the termination of DNA damage-induced cell-cycle checkpoint arrest to restart cell cycle by dephosphorylating and inactivating checkpoint kinases. Despite the high degree of conservation between cell-cycle checkpoint in yeast and mammals, it remains unknown whether or not protein phosphatases are involved in the termination of DNA damage-induced cell-cycle checkpoint arrest in mammals.
In mammals, the PP2C family of protein phosphatases consists of at least seven distinct isoforms, and have been implicated in stress response signalling. [22] [23] [24] Among members of the PP2C family, in particular, Wip1 (wild-type p53-inducible phosphatase 1) (PPM1D) possesses unique biological characteristics. Wip1 is induced by DNA damage in a p53-dependent manner, and inhibits ultraviolet (UV)-irradiation-induced p38 activation by dephosphorylating Thr180 in p38, thereby inhibiting the function of p53. 24, 25 It has been reported that the Wip1 (PPM1D) gene is amplified or overexpressed in various human cancers, including breast cancers, [26] [27] [28] [29] and that overexpression of Wip1 (PPM1D) complements the oncogenes Ras, Myc, and Neu1 for transformation of wild-type mouse embryonic fibroblasts (MEFs). 26 More recently, it has been shown that Wip1 associates with the nuclear isoform of uracil DNA glycosylase, UNG2, and that Wip1 suppresses DNA damage-induced base excision repair (BER) activity by dephosphorylating and inactivating UNG2. 30 In this study, we show that Wip1 interacts with Chk2 both physically and functionally in the nuclei. Wip1 dephosphorylates Thr68 in activated Chk2 both in vitro and in vitro, and inactivates Chk2 kinase activity toward Cdc25C. Furthermore, inhibition of Wip1 expression by RNA interference (RNAi) with Wip1 siRNA or p53 siRNA results in abnormally sustained Thr68 phosphorylation and kinase activation of Chk2 in response to DNA damage. We further show that RNAi-mediated inhibition of Wip1 expression results in enhanced apoptosis following DNA damage, and that ectopic expression of Wip1 suppresses Chk2-mediated apoptosis. Collectively, our in vitro and in vivo evidence suggests that Wip1 acts as a negative regulator of Chk2 during DNA damage responses, and that Wip1 plays an essential role in terminating DNA damage-induced cell-cycle checkpoint activation or in preventing cells from undergoing Chk2-mediated apoptosis in response to DNA damage.
Results and Discussion

Association of Chk2 with Wip1 in the nuclei
To better understand the roles and regulation of Chk2 during the DNA damage responses, we performed yeast two-hybrid screening using human Chk2 as a bait to identify potential associating molecule(s). From this screen, we identified Wip1, a p53-inducible oncogenic nuclear protein serine (S)/threonine (T) phosphatase [24] [25] [26] [27] [28] (data not shown). To test whether Chk2 can associate with Wip1 in vitro, we performed pulldown analyses using glutathione S-transferase (GST)-Chk2 (wild-type (WT)) or GST-Wip1 (WT) purified from Escherichia coli. As shown in Figure 1a , Flag-tagged Wip1 (WT) expressed in 293T cells associated specifically with GSTChk2 (WT), but not with GST. Conversely, haemagglutinin (HA)-tagged Chk2 (WT) expressed in 293T cells associated specifically with GST-Wip1 (WT), but not with GST ( Figure 1b) . These results indicate that Chk2 associates with Wip1 in vitro. Since it has been reported previously that both Chk2 and Wip1 are localized in the nuclei, 7, 17, 25, 31 their intracellular distribution was examined by immunofluorescence in 293T cells coexpressing HA-tagged GST-Chk2 (GST-HA-Chk2) and Flag-tagged Wip1 (Flag-Wip1) (see Materials and Methods). GST-HA-Chk2 and Flag-Wip1 colocalized primarily in the nuclei (see Supplementary Information). To determine whether Chk2 can associate with Wip1 in vivo, Flag-Wip1 (WT) was transiently expressed in 293T cells, either alone or with GST-HA-Chk2 (WT). Cells were harvested, and protein association was evaluated by co-precipitation with glutathione-Sepharose, followed by anti-Flag-immunoblotting. As shown in Figure 1c , in cells expressing both GST-HA-Chk2 and Flag-Wip1, glutathioneSepharose precipitation specifically co-precipitated Wip1, indicating that Chk2 associates with Wip1 in 293T cells.
We next examined whether endogenous Chk2 and Wip1 can interact in intact cells. To this end, we generated polyclonal anti-Chk2 and anti-Wip1 antibodies raised against human Chk2 peptides (amino acids (a.a.) 523-543) and GSThuman Wip1 (a.a. 1-458), respectively (see Materials and Methods), and evaluated specificities for their antigen recognition. As shown in Figure 1d (left panel), immunoblotting with anti-Chk2 antibody clearly detected HA-Chk2 (upper band) and endogenous Chk2 (lower band) in wholecell lysates and HA-Chk2 in anti-HA immunoprecipitates from 293T cells expressing HA-Chk2, and preadsorption of antiChk2 antibody with GST-Chk2 prior to immunoblotting resulted in a failure of the detection of HA-Chk2, confirming the specificity of anti-Chk2 antibody. Similarly, immunoblotting with anti-Wip1 antibody specifically detected FlagWip1 (Figure 1d , right panel). Specificities of anti-Wip1 and anti-Chk2 antibodies were further confirmed by an RNAi experiment where the bands detected by anti-Wip1 and antiChk2 antibodies were diminished in cells treated with Wip1 siRNAs and Chk2 siRNAs, respectively ( Figure 4 , data not shown). We examined the association of endogenous Chk2 and Wip1 in MCF7 cells that express Wip1 at a higher level. As shown in Figure 1e , endogenous Chk2 and Wip1 associated in MCF7 cells.
Effect of Wip1 on Thr68 phosphorylation of Chk2 induced by DNA damage or overexpression of Chk2
It was shown that ectopic overexpression of Chk2 in 293T cells results in its electrophoretic mobility shift (Figure 2a) , 13, 32 indicating auto-or transphosphorylation. In fact, electrophoretic mobility shift induced by overexpression of Chk2 was abrogated following treatment of cell extracts with CIP or BAP (data not shown). To examine the functional significance of the association between Wip1 and Chk2, HA-Chk2 (WT) or HA-Chk2 (DK) was expressed in 293T cells along with either Flag-Wip1 (WT) or Flag-Wip1 (D314A). Chk2 electrophoretic mobilities were monitored by anti-HA-immunoblotting of whole-cell lysates. Overexpression of Chk2 (WT), but not Chk2 (DK), resulted in decreased electrophoretic mobility (Figure 2a) , indicating that Chk2 kinase activity is required for this electrophoretic mobility shift. It had been shown previously that phosphorylation of Chk2 on Thr68 is required for full activation of Chk2 via auto-(trans-or cis)phosphorylation. [9] [10] [11] [12] [13] [31] [32] [33] [34] We therefore investigated the role of Thr68-phosphorylation in the electrophoretic mobility shift of Chk2. We found that a Chk2 mutant, the alanine68 mutant (HA-Chk2 (T68A)), did not undergo the mobility shift when overexpressed (data not shown), indicating that Thr68 is required. Intriguingly, this mobility shift was abrogated by coexpression of Wip1 (WT), but not Wip1 (D314A) (Figure 2a) , suggesting that Wip1 phosphatase activity can counteract Chk2 phosphorylation either directly or indirectly.
It has been shown previously that g-irradiation induces Thr68-phosphorylation and modification (activation) of Chk2. [9] [10] [11] [12] [13] Hence, we examined Thr68-phosphorylation and mobility shift of HA-Chk2 (WT) coexpressed with Flag-Wip1 (WT) or Flag-Wip1 (D314A) in 293T cells, before or after girradiation, by immunoblotting with antiphospho-Chk2 (Thr68). As shown in Figure 2b (upper panel), ectopic overexpression of HA-Chk2 per se induced some Thr68-autophosphorylation, but this phosphorylation, and that of the endogenous Chk2, was enhanced following g-irradiation, in cells not coexpressing Flag-Wip1 (WT). Antiphospho-Chk2 (Thr68) antibody failed to detect HA-Chk2 (T68A) expressed in 293T cells, demonstrating that this antibody specifically However, Thr68-phosphorylation and electrophoretic mobility shift of HA-Chk2 (WT) were inhibited in cells coexpressing Wip1 (WT), but not Wip1 (D314A) (Figure 2b ), indicating that the phosphatase activity of Wip1 is required for the inhibition of Chk2 Thr68-phosphorylation and mobility shift induced by overexpression of Chk2 and/or g-irradiation, although it was unclear whether Wip1 acted directly on Chk2. Since Wip1 belongs to the PP2C family of protein phosphatases, we examined whether or not other members of the PP2C family can exhibit similar effects. Coexpression of human PP2Ca2, mouse PP2Cb, PP2Ce, or PP2Cz fails to inhibit Thr68-phosphorylation and electrophoretic mobility shift of HAChk2 (WT) (Figure 2b , data not shown), indicating that the observed effects are at least selective to Wip1 among members of the PP2C family.
Effect of Wip1 on other phosphorylation sites in Chk2 induced by DNA damage or overexpression of Chk2
We next examined the effect of Wip1 (WT) on phosphorylation of several S and T residues other than Thr68 of Chk2, induced upon ectopic overexpression of Chk2 and/or g-irradiation, by immunoblotting with a series of phospho-Chk2 antibodies. As shown in Figure 2c , ectopic overexpression of HA-Chk2 per se induced weak phosphorylation of Ser19, Ser33/35, and Thr432 and strong (or apparent) phosphorylation of Thr387 and Ser516 of Chk2, and these phosphorylations were further enhanced following g-irradiation. Phosphorylation of Ser19, Ser33/35, Thr387, and Thr432 of HA-Chk2 induced by its overexpression and/or g-irradiation was also inhibited in cells coexpressing Wip1 (WT), but not Wip1 (D314A) (Figure 2c ). The result presented in Figure 2b suggests that dephosphorylation of phosphorylated-Thr68 in Chk2 by Wip1 may inhibit subsequent phosphorylation of Chk2 at several S/T residues, or that Wip1 may dephosphorylate these phosphorylated residues in Chk2 (see Figure 3a) . We also examined the effect of Wip1 (WT) on endogenous Chk2, and found that expression of Wip1 (WT), but not Wip1 (D314A), in 293T cells also inhibited Thr68-phosphorylation and mobility shift of the endogenous Chk2 ( Figure 2d ).
Dephosphorylation of Ser19, Ser33/35, Thr68, and Thr432, but not Thr387 and Ser516 in Chk2 by Wip1 in vitro
We next addressed the question of whether or not Wip1 could dephosphorylate Thr68 or Thr387 in Chk2. To this end, GSTWip1 (WT) and GST-Wip1 (D314A) were expressed in E. coli and purified using glutathione-Sepharose beads. Purified GST-Wip1 (WT), but not GST-Wip1 (D314A), exhibited phosphatase activity toward p-nitrophenyl phosphate (pNPP) (data not shown), confirming that each functions as expected with respect to phosphatase activity. In these assays, it was found that the pNPP phosphatase activity of purified GSTWip1 (WT) is Mg 2 þ dependent (data not shown), consistent with previous reports that Wip1 displays characteristics of the PP2C family of protein phosphatases. 25 These purified GST fusion proteins were subjected to an in vitro phosphatase assay using Thr68-and Thr387-phosphorylated HA-Chk2 as a substrate (see Materials and Methods). GST-Wip1 (WT), but not GST-Wip1 (D314A), dephosphorylated Thr68 in Chk2 in vitro (Figure 3a) , and this activity was time dependent and Mg 2 þ dependent (data not shown), characteristic of Wip1. On the other hand, GST-Wip1 (WT) failed to dephosphorylate Thr387 in Chk2 in vitro (Figure 3a) . These results are consistent with the idea that Wip1 can dephosphorylate the phosphorylated-Thr68 in Chk2 induced by g-irradiation or ectopic overexpression of Chk2, and that Thr68-phosphorylation of Chk2 is a prerequisite event for (trans-)phosphorylating Thr387 (and possibly Thr383) in Chk2 (see Figure 2c ). [31] [32] [33] [34] We also examined whether Wip1 could dephosphorylate Ser19, Ser33/35, Thr432, and Ser516 in Chk2. As shown in Figure 3a , GST-Wip1 (WT), but not GST-Wip1 (D314A), dephosphorylated-Ser19, -Ser33/35, -Thr432, but not Ser516 in Chk2 in vitro. The results of our in vitro phosphatase assays (Figure 3a ) (data not shown), 24 are summarized in Table 1 . As shown, Wip1 appears to dephosphorylate preferably a phosphorylated S or T followed by a glutamine (Q) in vitro.
Inhibition of Chk2 kinase activity by Wip1-mediated dephosphorylation of Thr68 in Chk2
It can be assumed that dephosphorylation of the phosphorylated-Thr68 in Chk2 by Wip1 may result in the inhibition of Chk2 kinase activity. To investigate this hypothesis, HA-Chk2 activated by ectopic overexpression and/or g-irradiation was immunoprecipitated with anti-HA antibody, treated with purified GST-Wip1 (WT) or GST-Wip1 (D314A), and was subjected to an in vitro kinase assay using GST-Cdc25C (a.a. 200-256) as a substrate (see Materials and Methods). However, it is possible that GST-Wip1, associated with HAChk2, may exhibit phosphatase activities toward phosphorylated-GST-Cdc25C by HA-Chk2 in this assay. It was found that GST-Wip1 (WT) failed to dephosphorylate the phosphorylated-GST-Cdc25C by HA-Chk2 in vitro (data not shown), indicating that phosphorylated-GST-Cdc25C is not a substrate of Wip1 at least in vitro. Considering the finding that Wip1 dephosphorylates the phosphorylated-Ser33/35 and -Thr68, but not phosphorylated-Thr387 in Chk2 in vitro (Figure 3a) , the result also suggests the substrate specificity of Wip1. Interestingly, incubation of immunoprecipitated HA-Chk2 (activated by its ectopic overexpression and/or g-irradiation) with GST-Wip1 (WT), but not GST-Wip1 (D314A), resulted in a drastic inhibition of Chk2 kinase activity toward GST-Cdc25C in vitro (Figure 3b) . Furthermore, coexpression of Flag-Wip1 (WT), but not Flag-Wip1 (D314A) in 293T cells, resulted in a drastic inhibition of Chk2 kinase activity in vitro (Figure 3c ), confirming that Wip1 inhibits Chk2 kinase activity by dephosphorylating the phosphorylatedThr68 in Chk2.
Abnormally sustained Thr68 phosphorylation and kinase activity of Chk2 by inhibition of Wip1 expression
Considering our results indicating that Wip1 dephosphorylates and inactivates Chk2, it is likely that Wip1 acts as a negative regulator of Chk2 during DNA damage responses. To test such a possibility, we performed an RNAi experiment with Wip1 siRNAs or control siRNAs and monitored the effects of inhibition of Wip1 expression on the extent of Thr68-phosphorylation and kinase activity of Chk2 following g-irradiation. In this experiment, p53-proficient MCF7 and HCT116 cells were utilized (see Materials and Methods). At 3 days after transfection, expression levels of Wip1 protein in cells transfected with Wip1 siRNAs decreased drastically compared to cells transfected with control siRNAs, as assayed by immunoblot analysis (Figure 4a , data not shown). In cells transfected with control siRNAs, Thr68-phosphorylation and kinase activity of Chk2 increased following g-irradiation and decreased rapidly thereafter, while increased Thr68-phosphorylation and kinase activity of Chk2 were abnormally sustained in cells transfected with Wip1 siRNAs following g-irradiation (Figure 4a , data not shown). A sustained electrophoretic mobility shift of Chk2 was also observed in cells transfected with Wip1 siRNAs following girradiation compared to cells transfected with control siRNAs. These results support the notion that Wip1 induced by DNA damage acts as a negative regulator of Chk2 in the DNA damage response.
Since Wip1 was identified as 'wild-type p53-inducible phosphatase 1', 25 we next examined the effect of inhibition of p53 expression by p53 siRNA on the extent of g-irradiationinduced expression of Wip1 and Thr68-phosphorylation of Chk2 (see Materials and Methods). As shown in Figure 4b , in MCF7 cells transfected with control siRNAs, upon g-irradiation apparent induction of p53 proteins (reached maximal levels within 2 h) followed by induction of Wip1 proteins (reached maximal levels between 2 and 4 h) were observed, while transfection of MCF7 cells with p53 siRNAs resulted in inhibition of induction of both p53 and Wip1 proteins following g-irradiation. Consistent with suppressed expression of Wip1 proteins in MCF7 cells transfected with p53 siRNAs following g-irradiation, increased Thr68-phosphorylation of Chk2 was abnormally sustained in cells transfected with p53 siRNAs following g-irradiation compared to cells transfected with control siRNAs (Figure 4b) . Thus, the result indicates that p53 contributes to dephosphorylation of the phosphorylatedThr68 in Chk2 at later points (4-8 h) of DNA damage-induced responses by regulating the induction of Wip1 proteins following g-irradiation. . Glutamine residues following phosphorylated serine or threonine residues were underlined.
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Antagonistic effect of Wip1 on Chk2-dependent apoptosis
To understand the role of Wip1 in regulating cellular function, we monitored the effect of inhibition of Wip1 expression on the extent of g-irradiation-induced apoptosis by TUNEL assays (see Materials and Methods). As shown in Figure 5a , MCF7 cells transfected with Wip1 siRNAs, but not control siRNAs, exhibited remarkably enhanced apoptosis following g-irradiation, indicating that Wip1 negatively regulates g-irradiationinduced apoptosis by dephosphorylating and inactivating Chk2. Similar results were obtained when p53-proficient At the indicated time points after g-irradiation, WCLs from the respective transfectants were subjected to immunoblotting with anti-p53, anti-Wip1, antiphospho-Chk2 (Thr68), or anti-Chk2 antibodies, and the intensity of the respective bands was quantified. Histograms show quantification of expression levels of p53 and Wip1 proteins, respectively (upper, middle panels). Relative levels of Thr68-phosphorylation of Chk2 (lower panel) were determined by normalization with levels of Chk2 proteins in the respective samples. Data are expressed as the mean7S.D. (relative to the levels in nonirradiated cells with control siRNA) in three independent experiments. Representative results (at 4 h after g-irradiation) of the immunoblots are also indicated HCT116 cells, transfected with control siRNAs or Wip1 siRNAs, were subjected to TUNEL assays following girradiation (data not shown). Furthermore, g-irradiationinduced apoptosis was inhibited by Chk2 siRNAs (data not shown). Moreover, it was found that ectopic expression of HA-Chk2 (WT) by itself in MCF7 cells enhanced g-irradiationinduced apoptosis, but was inhibited by coexpression of FlagWip1 (WT), but not Flag-Wip1 (D314A), indicating that Wip1 antagonizes Chk2-mediated apoptosis in a phosphatase activity-dependent manner (Figure 5b) . It has been reported that phosphorylation of Ser516 in Chk2 is required for radiation-induced apoptosis. 35 Thus, the inhibition of Chk2-mediated apoptosis by Wip1 following g-irradiation can be explained by our observation that ectopic coexpression of Wip1 inhibits phosphorylation of Ser516 in Chk2 (Figure 2c ). Taken together, these results indicate that enhanced apoptosis induced by Wip1 siRNA is dependent both on girradiation and on Chk2, and that Wip1 acts as a negative regulator during g-irradiation-induced apoptosis. In this respect, it is of interest to note that fibroblasts from Wip1-null embryos exhibit a decreased proliferation rate. 36 It has been reported that Wip1 contributes to suppression of UVirradiation-induced apoptosis by dephosphorylating and inactivating p38. 24 However, g-irradiation-induced apoptosis of MCF7 cells transfected with Wip1 siRNAs was unaffected in the absence or presence of the specific inhibitor of p38, SB203580 (data not shown).
Chk2 mutations have been found in patients having a variant form of the familial multicancer Li-Fraumeni syndrome, and Chk2 kinase is considered to be a tumour suppressor. 7, 8, 37 In contrast, Wip1 phosphatase is considered to be an oncogenic protein, on the basis of the findings that the gene encoding Wip1 (PPM1D) is amplified in human breast cancers, [26] [27] [28] and that disruption of the Wip1 gene activates p53 and p16
Ink4a -p19 Arf pathway via p38 MAPK signalling, resulting in the suppression of in vitro transformation of MEFs and of in vivo tumorigenesis by oncogenes. 38, 39 It has also been reported that following DNA damage ATM phosphorylates Chk2 at Thr68, an event critical for the activation of Chk2. [9] [10] [11] [12] [13] Here we show that Wip1 dephosphorylates Thr68 in Chk2 both in vivo and in vitro (Figures 2 and 3) , and may act as a negative regulator of Chk2 (Figures 4b and 5) . It has been reported that Ptc2 and Ptc3, two members of the PP2C family, bind to Rad53 and inactivate Rad53-dependent pathways in S. cerevisiae. 21 Considering our results, it is likely that Ptc2 and Ptc3 inactivate Rad53 by dephosphorylating it. Furthermore, we provide evidence suggesting that Wip1 may (Figures 4 and 5) . However, at present we cannot rule out the possibility that Wip1 may dephosphorylate and inactivate ATM or other proteins, thereby inhibiting Chk2 function. Interestingly, it has been recently reported that Wip1 dephosphorylates the nuclear form of uracil DNA glycosylase (UNG2) and Chk1, thereby suppressing BER and intra-S and G2/M checkpoint regulation, respectively. 30, 40 In the case of UNG2 and p38, phosphorylation sites on these molecules, which can be targets for Wip1-mediated dephosphorylation, reveal consensus sequences 'phospho-T-X-phospho-Tyr (Y) (or phospho-T-X-Y, X: optional a.a.)'. 41 In this respect, it is important to note that our in vitro evidence as well as previous report 40 indicate the presence of additional target sequences for Wip1, which are 'phospho-S-Q' or 'phospho-T-Q', well-known fingerprints of ATM kinase (see Table 1 ). Future study to identify a substrate(s) for Wip1 in addition to phosphorylatedChk2, -Chk1, -p38, 24 and -UNG2 30 may contribute to our understanding of the roles of Wip1 during DNA damageinduced cellular responses.
Materials and Methods
Plasmid constructions
The human Chk2 coding region was amplified by PCR using human placenta cDNA as a template, and subcloned into the mammalian expression vector pcDNA3 (Invitrogen). The mutant Chk2 (T68A) was generated by replacing Thr68 with Ala using the Transformer TM SiteDirected mutagenesis kit (Clontech). The kinase-dead mutant of Chk2 (DK) replaces Lys249 with Arg and was created by PCR. A PCR-based procedure was employed to attach an HA tag at the C-terminal end of Chk2; to generate the expression vectors, pcDNA-Chk2 (WT)-HA, pcDNAChk2 (T68A)-HA, pcDNA-Chk2 (DK)-HA, and pEBG-Chk2 (encoding GST-HA-Chk2) were constructed to attach GST and HA tags at the N-and C-terminal ends of Chk2, respectively. pGEX-3X-Chk2, encoding GSTChk2 fusion proteins, was constructed to attach GST tag at the N-terminal end of Chk2; pGEX-3X-Cdc25C, encoding GST-Cdc25C (a.a. 200-256 of human Cdc25C), was constructed by subcloning of the PCR amplified Cdc25C cDNA fragment into the pGEX-3X to generate GST-Cdc25C. pCMV-Wip1 (WT), and pCMV-Wip1 (D314A), encoding the wild-type and phosphatase inactive mutant of Wip1, respectively, were constructed as described previously. 24 A PCR-based procedure was employed to attach a FLAG-tag sequence at the C-terminal end of Wip1 to generate pcDNAWip1 (WT)-FLAG and pcDNA-Wip1 (D314A)-FLAG. pGEX-5X-Wip1 (WT) and pGEX-5X-Wip1 (D314A), encoding GST-Wip1 (WT) and GST-Wip1 (D314A), respectively, were constructed as described previously. 24 pcDNA-PP2Ca2 (WT)-FLAG, encoding the wild-type Flag-PP2Ca2, was constructed as described previously. 23 pcDNA-Chk1-myc, encoding the wild-type Chk1 of mouse origin, was a gift from Noboru Motoyama (National Institute for Longevity Sciences, Japan).
Antibodies, cells, and DNA transfection
The following antibodies were used: mouse monoclonal antibody Mouse monoclonal anti-Wip1 (WC 10) antibody was from Trevigen. Mouse monoclonal anti-p53 (DO-1) antibody was from Santa Cruz. Rabbit polyclonal anti-phospho-Chk1 (Ser317 and Ser345) antibodies, antiphospho-Chk2 (Ser19, Ser33/35, Thr68, Thr387, Thr432, and Ser516) antibodies, and anti-phospho-p53 (Ser15, Ser20, and Ser46) antibodies were purchased from Cell Signaling. Alexa Fluor 546 (goat anti-mouse IgG, red) and Alexa Fluor 488 (goat anti-rat IgG, green) were purchased from Molecular Probes. SB203580, a specific inhibitor of p38 MAP kinase (p38a, p38b, and p38b2), was from Promega. HEK293T (293T), MCF7 cells were maintained in Dulbecco's modified Eagle's medium (Nissui) supplemented with 10% (v/v) foetal calf serum (FCS). HCT116 cells were maintained in McCoy's 5a medium (GibcoBRL) supplemented with 10% (v/v) FCS. It should be noted that 293T cells bear p53 inactivated by adenovirus E1B and SV40 T-antigen, while MCF7 and HCT116 cells are p53-proficient breast adenocarcinoma and colorectal carcinoma cells, respectively. Transient cDNA transfection into cells was performed using the calcium phosphate method 3 or Lipofectamine Reagent, PLUS Reagent, and Lipofectamine 2000 Reagent (GibcoBRL) according to the manufacturer's instructions.
Preparation of cell lysates and co-(immuno) precipitation analysis
Transfected cells were solubilized with lysis buffer (50 mM Tris-HCl (pH 7.4), 0.5% (v/v) NP-40, 150 mM NaCl, 5 mM EDTA, 50 mM NaF, 1 mM Na 3 VO 4 , 1 mM phenylmethyl sulphonyl fluoride (PMSF), 10 mg/ml aprotinin), and cell lysates were prepared by centrifugation at 12 000 Â g for 15 min at 41C. Subsequently, the cell lysates were subjected to pull-down assay/immunoblot analysis or co-(immuno) precipitation/immunoblot analysis. For co-(immuno) precipitation analysis, the cell lysates were precleared with protein A-Sepharose (Amersham Pharmacia Biotech) for 1 h at 41C. The precleared supernatants were then co-(immuno) precipitated with glutathione-Sepharose beads (Amersham Pharmacia Biotech) or with anti-HA antibody conjugated to protein ASepharose beads for 2 h at 41C. The resultant precipitates were washed five times with lysis buffer, and eluted with Laemmli sample buffer.
Expression and purification of GST fusion proteins
The plasmids encoding the GST fusion proteins, GST-Chk2 (WT), GSTWip1 (WT), GST-Wip1 (D314A), and GST-Cdc25C (a.a. 200-256), were constructed using the pGEX plasmids (Amersham Pharmacia Biotech). GST fusion proteins expressed in E. coli DH5a were extracted with phosphate-buffered saline (PBS) containing 1% (v/v) Triton X-100, 1 mM EDTA, 1 mM PMSF, 10 mg/ml leupeptin, and 10 mg/ml aprotinin, and were isolated with glutathione-Sepharose beads. To further purify GST-Wip1 (WT), GST-Wip1 (D314A), and GST-Cdc25C for phosphatase and kinase assays, fusion proteins were eluted from beads by incubating with 25 mM glutathione (reduced), followed by dialysis prior to use.
Pull-down assay and immunoblot analysis
The cell lysates were precleared with glutathione-Sepharose for 1 h at 41C. The precleared supernatant was then incubated with the respective GST fusion proteins conjugated with glutathione-Sepharose beads for 1 h Regulation of Chk2 kinase by Wip1 phosphatase H Fujimoto et al at 41C, washed five times with lysis buffer, and eluted with Laemmli sample buffer. Precipitates either from the pull-down assay or whole-cell lysates were separated by SDS-PAGE (10% PAG), and transferred onto PVDF membrane filters (Immobilon P, Millipore). The membranes were immunoblotted with the respective antibodies, and bound antibodies were visualized with HRP-conjugated antibodies against mouse or rabbit IgGs (Bio-Rad) using the chemiluminescence reagent (Renaissance, NEN). Quantification of the immunoblots was performed by densitometric scanning of the film using an Image Analysis system with NIH Image 1.62 software.
In vitro phosphatase assay and kinase assays
To prepare phosphorylated-HA-Chk2 (WT), 293T cells were transfected with the expression vector encoding HA-Chk2 (WT). For in vitro kinase assay, 24 h after transfection, cells were exposed to 10 Gy g-irradiation, and harvested 1 h later. Phosphorylated-HA-Chk2 (WT) was immunoprecipitated with anti-HA antibody, washed five times with lysis buffer, and resuspended in 50 ml phosphatase buffer (50 mM Tris-HCl (pH 7.5), 30 mM MgCl 2 , 1 mg/ml bovine serum albumin, 0.05% 2-mercaptoethanol).
The in vitro phosphatase reaction was initiated by addition of purified GSTWip1 (WT) or GST-Wip1 (D314A), and allowed to incubate for 1 h at 301C. Samples were separated by SDS-PAGE (9% PAG), and transferred onto PVDF membrane filters. Immunoblot analysis was performed with antiphospho-Chk2 (Ser19, Ser33/35, Thr68, Thr387, Thr432, or Ser516) antibody to monitor the extent of Ser19, Ser33/35, Thr68, Thr387, Thr432, or Ser516-phosphorylation in Chk2 in the respective samples. The amounts of phosphorylated HA-tagged Chk2 (WT) were assessed by anti-HA immunoblot analysis. Kinase activities of Chk2 after treatment with bacterial expressed GST-Wip1 (WT) or GST-Wip1 (D314A) in vitro were determined as follows: samples treated with either GST-Wip1 (WT) or GST-Wip1 (D314A) were washed once with kinase buffer (10 mM HEPES-NaOH (pH 7.5), 5 mM MgCl 2 , 2 mM DTT), resuspended in 30 ml of the kinase buffer containing 2 mg GST-Cdc25C (a.a. 200-256), and 15 mCi of [g-32 P]ATP (5000 Ci/mmol; Amersham), and incubated for 30 min at 301C. The reactions were terminated by the addition of Laemmli sample buffer, separated by SDS-PAGE (12% PAG), and were subjected to autoradiography. Kinase activities of Chk2 in cells coexpressing FlagWip1 (WT) or Flag-Wip1 (D314A) or in cells transfected with Wip1 siRNAs or control siRNAs (see below) were also determined similarly using GSTCdc25C (a.a. 200-256) as a substrate following anti-HA or anti-Chk2 immunoprecipitation, respectively.
siRNA
The siRNA duplexes were 21 bp including a 2-base deoxynucleotide overhang synthesized by Dharmacon Research. The sequence of the Wip1 siRNA oligo was UUGGCCUUGUGCCUACUAA. The sequence of the p53 siRNA oligo was GCAAUGGAUGAUUUGAUGC. The control siRNA oligo used (Scramble II Duplex) was GCGCGCUUUGUAG GAUUCG. Cells were transfected with siRNA duplexes using GeneSilencer (Gene Therapy Systems) following the manufacturer's instructions.
TUNEL assays
Cells were transfected with the Wip1 siRNAs or control siRNAs or GST-HA-Chk2 or Flag-Wip1 as described above, subjected to g-irradiation (20 Gy), and cultured for 36 h. By using the MEBSTAIN Apoptosis Kit II (MBL), TUNEL assays were performed following the protocol recommended by the manufacturer. In brief, cells were washed with PBS, fixed with 1% (w/v) formaldehyde in PBS for 15 min at 41C, and ethanol/acetic acid solution (2 : 1) for 5 min at À201C. DNA fragmentation was nick endlabelled with biotinylated dUTP, mediated by TdT for 1 h at 371C, and subsequently stained with FITC-conjugated avidin. The nuclei were stained with DAPI or Hoechst. Samples were visualized using an inverted confocal microscope (Zeiss).
Immunofluorescence
Cells grown on coverslips coated by rat-tail collagen were fixed in 4% paraformaldehyde/PBS for 15 min at room temperature and then permeabilized with PBS containing 0.1% Triton X-100 for 15 min at room temperature. After blocking in PBS with 10% FCS for 30 min, cells were incubated with primary antibodies, anti-FLAG MoAb (M2, 1 : 500), and/or anti-HA monoclonal Ab (3F10, 1 : 200), in PBS/10% FCS for 30 min at room temperature. Cell were washed twice with PBS and then incubated with secondary antibodies, Alexa Fluor 546 (goat anti-mouse IgG, 1 : 500) and/or Alexa Fluor 488 (goat anti-rat IgG, 1 : 200), in PBS/10% FCS at room temperature for 30 min. After two washes in PBS, the cells were mounted with Pristine Mount (Research Genetics) and analysed with an inverted confocal microscope (Zeiss).
